

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to ethanol (GO:0048149) | 9.10857167 |
| 2 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 8.61429546 |
| 3 | ether lipid metabolic process (GO:0046485) | 7.31965634 |
| 4 | regulation of protein glycosylation (GO:0060049) | 6.72163314 |
| 5 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 6.61837031 |
| 6 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 6.23531511 |
| 7 | negative regulation of cAMP-mediated signaling (GO:0043951) | 6.12035823 |
| 8 | sphingosine metabolic process (GO:0006670) | 5.90734039 |
| 9 | opioid receptor signaling pathway (GO:0038003) | 5.62633061 |
| 10 | regulation of translational termination (GO:0006449) | 5.37565964 |
| 11 | diol metabolic process (GO:0034311) | 5.26218519 |
| 12 | mRNA cleavage (GO:0006379) | 5.16313934 |
| 13 | glycerol ether metabolic process (GO:0006662) | 5.09037841 |
| 14 | sphingoid metabolic process (GO:0046519) | 4.94379708 |
| 15 | regulation of acrosome reaction (GO:0060046) | 4.87194147 |
| 16 | adult feeding behavior (GO:0008343) | 4.75821623 |
| 17 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.67396007 |
| 18 | ether metabolic process (GO:0018904) | 4.64523304 |
| 19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.52603682 |
| 20 | brain morphogenesis (GO:0048854) | 4.52546095 |
| 21 | ovulation cycle (GO:0042698) | 4.39393554 |
| 22 | aggressive behavior (GO:0002118) | 4.38289350 |
| 23 | cellular response to interferon-alpha (GO:0035457) | 4.35232990 |
| 24 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.32153578 |
| 25 | piRNA metabolic process (GO:0034587) | 4.14878315 |
| 26 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.12621909 |
| 27 | pyrimidine dimer repair (GO:0006290) | 4.12369143 |
| 28 | vagina development (GO:0060068) | 3.86102187 |
| 29 | thrombin receptor signaling pathway (GO:0070493) | 3.86027942 |
| 30 | regulation of extracellular matrix disassembly (GO:0010715) | 3.85516458 |
| 31 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.79053569 |
| 32 | smooth muscle tissue development (GO:0048745) | 3.77216383 |
| 33 | N-terminal protein amino acid acetylation (GO:0006474) | 3.72089711 |
| 34 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.70403267 |
| 35 | cellular response to ammonium ion (GO:0071242) | 3.67268763 |
| 36 | positive regulation of natural killer cell activation (GO:0032816) | 3.60321840 |
| 37 | mitotic cell cycle arrest (GO:0071850) | 3.57643277 |
| 38 | endothelium development (GO:0003158) | 3.55236470 |
| 39 | fibroblast migration (GO:0010761) | 3.50682162 |
| 40 | photoreceptor cell maintenance (GO:0045494) | 3.43752921 |
| 41 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.43516396 |
| 42 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.43058685 |
| 43 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.43058685 |
| 44 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.41740412 |
| 45 | hepatocyte apoptotic process (GO:0097284) | 3.38139105 |
| 46 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.35676950 |
| 47 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.35309879 |
| 48 | response to pheromone (GO:0019236) | 3.35298028 |
| 49 | relaxation of smooth muscle (GO:0044557) | 3.30995180 |
| 50 | positive regulation of protein autophosphorylation (GO:0031954) | 3.30499806 |
| 51 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.30286623 |
| 52 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.18417608 |
| 53 | NADH dehydrogenase complex assembly (GO:0010257) | 3.18417608 |
| 54 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.18417608 |
| 55 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.15655230 |
| 56 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.13713847 |
| 57 | negative regulation of cell aging (GO:0090344) | 3.13572874 |
| 58 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.13056492 |
| 59 | forebrain morphogenesis (GO:0048853) | 3.10739656 |
| 60 | muscle organ morphogenesis (GO:0048644) | 3.09069814 |
| 61 | coenzyme catabolic process (GO:0009109) | 3.08587997 |
| 62 | regulation of Rac protein signal transduction (GO:0035020) | 3.07263815 |
| 63 | cellular response to alkaloid (GO:0071312) | 3.04382420 |
| 64 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.99057145 |
| 65 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.97501811 |
| 66 | protein complex biogenesis (GO:0070271) | 2.96524460 |
| 67 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.93625984 |
| 68 | regulation of natural killer cell differentiation (GO:0032823) | 2.93353629 |
| 69 | negative regulation of exocytosis (GO:0045920) | 2.91465065 |
| 70 | nitric oxide mediated signal transduction (GO:0007263) | 2.90616352 |
| 71 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.87885956 |
| 72 | regulation of helicase activity (GO:0051095) | 2.87831991 |
| 73 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.86160836 |
| 74 | branched-chain amino acid catabolic process (GO:0009083) | 2.85107771 |
| 75 | proteasome assembly (GO:0043248) | 2.80405273 |
| 76 | regulation of hypersensitivity (GO:0002883) | 2.76147173 |
| 77 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.75570309 |
| 78 | microtubule severing (GO:0051013) | 2.73166289 |
| 79 | female genitalia development (GO:0030540) | 2.68625586 |
| 80 | succinate metabolic process (GO:0006105) | 2.62265203 |
| 81 | respiratory chain complex IV assembly (GO:0008535) | 2.62034178 |
| 82 | quinone biosynthetic process (GO:1901663) | 2.61971959 |
| 83 | ncRNA catabolic process (GO:0034661) | 2.61187643 |
| 84 | single strand break repair (GO:0000012) | 2.59808078 |
| 85 | branched-chain amino acid metabolic process (GO:0009081) | 2.59234573 |
| 86 | regulation of glycoprotein biosynthetic process (GO:0010559) | 2.59078425 |
| 87 | regulation of execution phase of apoptosis (GO:1900117) | 2.58097045 |
| 88 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.53515820 |
| 89 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.53225723 |
| 90 | tachykinin receptor signaling pathway (GO:0007217) | 2.51196662 |
| 91 | platelet dense granule organization (GO:0060155) | 2.50982710 |
| 92 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.49721250 |
| 93 | ribonucleoprotein complex disassembly (GO:0032988) | 2.49700577 |
| 94 | neuron remodeling (GO:0016322) | 2.47035718 |
| 95 | tRNA modification (GO:0006400) | 2.46918016 |
| 96 | positive regulation of cholesterol transport (GO:0032376) | 2.45622406 |
| 97 | positive regulation of sterol transport (GO:0032373) | 2.45622406 |
| 98 | regulation of natural killer cell activation (GO:0032814) | 2.45436726 |
| 99 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.45221846 |
| 100 | cytochrome complex assembly (GO:0017004) | 2.44442408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.13625617 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.62852535 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.85225183 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.77300931 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.01418586 |
| 6 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.60884069 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.58631503 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.53688115 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.52952550 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.52309612 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.40246474 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.22918787 |
| 13 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.21749109 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96256642 |
| 15 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.92823114 |
| 16 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.92823114 |
| 17 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.92814770 |
| 18 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.87005159 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.82640293 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81801974 |
| 21 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.81718572 |
| 22 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.78572389 |
| 23 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.78572389 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.75278375 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73731521 |
| 26 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.72218311 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.68500198 |
| 28 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.66153976 |
| 29 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.62370684 |
| 30 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.62037391 |
| 31 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.59000513 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.56790281 |
| 33 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.56248622 |
| 34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.54839696 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53019769 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52131843 |
| 37 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.49438238 |
| 38 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.48624032 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.44839336 |
| 40 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.43938738 |
| 41 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.43751130 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.43441432 |
| 43 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37465045 |
| 44 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.36331258 |
| 45 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.33828497 |
| 46 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.33598110 |
| 47 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.33023024 |
| 48 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.30971426 |
| 49 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.28080462 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.22178231 |
| 51 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19766875 |
| 52 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19004086 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18467032 |
| 54 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.15696149 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15635851 |
| 56 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15632437 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.15032731 |
| 58 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13211747 |
| 59 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12075224 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10107747 |
| 61 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.09873204 |
| 62 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.08360830 |
| 63 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07959266 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06415919 |
| 65 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06288608 |
| 66 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.04828971 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03828878 |
| 68 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.01470193 |
| 69 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99433729 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99353164 |
| 71 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98460098 |
| 72 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97352981 |
| 73 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.97264370 |
| 74 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97096111 |
| 75 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97096111 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97010805 |
| 77 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.96473532 |
| 78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95256390 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94500303 |
| 80 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.92971599 |
| 81 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.92897802 |
| 82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.92734618 |
| 83 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92424564 |
| 84 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91880674 |
| 85 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91572338 |
| 86 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.91193782 |
| 87 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90141788 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90138289 |
| 89 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.89990816 |
| 90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89833072 |
| 91 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.89306355 |
| 92 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.87853769 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87540550 |
| 94 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87292330 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86406264 |
| 96 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85734148 |
| 97 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85323752 |
| 98 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.84817759 |
| 99 | NFYB_21822215_ChIP-Seq_K562_Human | 0.84302183 |
| 100 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84234136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 4.58632357 |
| 2 | MP0005360_urolithiasis | 4.16092861 |
| 3 | MP0009780_abnormal_chondrocyte_physiolo | 3.96330483 |
| 4 | MP0000015_abnormal_ear_pigmentation | 3.75903443 |
| 5 | MP0009278_abnormal_bone_marrow | 3.75555897 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.23721802 |
| 7 | MP0002876_abnormal_thyroid_physiology | 3.03099773 |
| 8 | MP0003195_calcinosis | 2.75188842 |
| 9 | MP0006035_abnormal_mitochondrial_morpho | 2.59218488 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.58735455 |
| 11 | MP0005084_abnormal_gallbladder_morpholo | 2.56983577 |
| 12 | MP0002254_reproductive_system_inflammat | 2.56165145 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.37270722 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.37270722 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.29196298 |
| 16 | MP0005646_abnormal_pituitary_gland | 2.19090812 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.16527300 |
| 18 | MP0005310_abnormal_salivary_gland | 1.97888727 |
| 19 | MP0005645_abnormal_hypothalamus_physiol | 1.94495398 |
| 20 | MP0001501_abnormal_sleep_pattern | 1.87346778 |
| 21 | MP0009764_decreased_sensitivity_to | 1.85573807 |
| 22 | MP0008775_abnormal_heart_ventricle | 1.85477543 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.84699850 |
| 24 | MP0005503_abnormal_tendon_morphology | 1.75814183 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.67808043 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 1.64445298 |
| 27 | MP0005332_abnormal_amino_acid | 1.58368203 |
| 28 | MP0005174_abnormal_tail_pigmentation | 1.58002300 |
| 29 | MP0003136_yellow_coat_color | 1.57259464 |
| 30 | MP0008004_abnormal_stomach_pH | 1.56772843 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.54827254 |
| 32 | MP0003633_abnormal_nervous_system | 1.53648537 |
| 33 | MP0003045_fibrosis | 1.52160137 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.50623696 |
| 35 | MP0001664_abnormal_digestion | 1.45704280 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.43748641 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.43550832 |
| 38 | MP0001756_abnormal_urination | 1.36742640 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.36720184 |
| 40 | MP0008058_abnormal_DNA_repair | 1.35128759 |
| 41 | MP0000681_abnormal_thyroid_gland | 1.33848903 |
| 42 | MP0008057_abnormal_DNA_replication | 1.33544866 |
| 43 | MP0002168_other_aberrant_phenotype | 1.32737013 |
| 44 | MP0000003_abnormal_adipose_tissue | 1.30252945 |
| 45 | MP0004134_abnormal_chest_morphology | 1.23985736 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.22656985 |
| 47 | MP0001970_abnormal_pain_threshold | 1.19600234 |
| 48 | MP0000358_abnormal_cell_content/ | 1.19551900 |
| 49 | MP0001661_extended_life_span | 1.18811967 |
| 50 | MP0001485_abnormal_pinna_reflex | 1.14086884 |
| 51 | MP0003941_abnormal_skin_development | 1.13047992 |
| 52 | MP0002090_abnormal_vision | 1.11808471 |
| 53 | MP0003724_increased_susceptibility_to | 1.11188403 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.08164277 |
| 55 | MP0006072_abnormal_retinal_apoptosis | 1.07207178 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.07096831 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.03148047 |
| 58 | MP0002006_tumorigenesis | 1.00846238 |
| 59 | MP0008877_abnormal_DNA_methylation | 0.97917053 |
| 60 | MP0003075_altered_response_to | 0.97740623 |
| 61 | MP0010307_abnormal_tumor_latency | 0.95485800 |
| 62 | MP0003959_abnormal_lean_body | 0.94337539 |
| 63 | MP0001851_eye_inflammation | 0.91440710 |
| 64 | MP0000685_abnormal_immune_system | 0.90975232 |
| 65 | MP0009046_muscle_twitch | 0.90448892 |
| 66 | MP0002009_preneoplasia | 0.90191630 |
| 67 | MP0003646_muscle_fatigue | 0.89143838 |
| 68 | MP0002971_abnormal_brown_adipose | 0.87091464 |
| 69 | MP0002095_abnormal_skin_pigmentation | 0.85120316 |
| 70 | MP0002166_altered_tumor_susceptibility | 0.84642519 |
| 71 | MP0005623_abnormal_meninges_morphology | 0.83987727 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 0.82871398 |
| 73 | MP0003638_abnormal_response/metabolism_ | 0.80619901 |
| 74 | MP0003329_amyloid_beta_deposits | 0.78366288 |
| 75 | MP0003631_nervous_system_phenotype | 0.77810997 |
| 76 | MP0000749_muscle_degeneration | 0.77761662 |
| 77 | MP0001486_abnormal_startle_reflex | 0.77646082 |
| 78 | MP0005367_renal/urinary_system_phenotyp | 0.76390571 |
| 79 | MP0000516_abnormal_urinary_system | 0.76390571 |
| 80 | MP0001835_abnormal_antigen_presentation | 0.74947059 |
| 81 | MP0002796_impaired_skin_barrier | 0.74391591 |
| 82 | MP0009745_abnormal_behavioral_response | 0.68741761 |
| 83 | MP0010329_abnormal_lipoprotein_level | 0.68558075 |
| 84 | MP0005165_increased_susceptibility_to | 0.68047445 |
| 85 | MP0006082_CNS_inflammation | 0.67331587 |
| 86 | MP0001764_abnormal_homeostasis | 0.67149532 |
| 87 | MP0000604_amyloidosis | 0.66371349 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.65279051 |
| 89 | MP0005389_reproductive_system_phenotype | 0.63118975 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.62849482 |
| 91 | MP0004484_altered_response_of | 0.62245896 |
| 92 | MP0002163_abnormal_gland_morphology | 0.61960981 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 0.61498582 |
| 94 | MP0001879_abnormal_lymphatic_vessel | 0.61371799 |
| 95 | MP0002102_abnormal_ear_morphology | 0.61368591 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.61155144 |
| 97 | MP0004147_increased_porphyrin_level | 0.59289436 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.58081098 |
| 99 | MP0001984_abnormal_olfaction | 0.57171452 |
| 100 | MP0000427_abnormal_hair_cycle | 0.55757044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thyroid-stimulating hormone excess (HP:0002925) | 8.08892832 |
| 2 | Sensory axonal neuropathy (HP:0003390) | 5.99533559 |
| 3 | Volvulus (HP:0002580) | 5.60117293 |
| 4 | Facial diplegia (HP:0001349) | 4.43568073 |
| 5 | Progressive inability to walk (HP:0002505) | 4.21488310 |
| 6 | Large for gestational age (HP:0001520) | 3.98079548 |
| 7 | Hyperthyroidism (HP:0000836) | 3.91454294 |
| 8 | Intestinal atresia (HP:0011100) | 3.78553092 |
| 9 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.64024512 |
| 10 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.59781024 |
| 11 | Poor head control (HP:0002421) | 3.57057781 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.04695146 |
| 13 | Hypoproteinemia (HP:0003075) | 2.85975385 |
| 14 | Neuroendocrine neoplasm (HP:0100634) | 2.80058645 |
| 15 | Myositis (HP:0100614) | 2.70513796 |
| 16 | Poor speech (HP:0002465) | 2.64939421 |
| 17 | Pheochromocytoma (HP:0002666) | 2.64510887 |
| 18 | Constricted visual fields (HP:0001133) | 2.63901144 |
| 19 | Chromsome breakage (HP:0040012) | 2.60707892 |
| 20 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.60290618 |
| 21 | Broad alveolar ridges (HP:0000187) | 2.60196810 |
| 22 | Thickened helices (HP:0000391) | 2.59603041 |
| 23 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.59246283 |
| 24 | Attenuation of retinal blood vessels (HP:0007843) | 2.55547413 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.55056199 |
| 26 | Lipid accumulation in hepatocytes (HP:0006561) | 2.53449248 |
| 27 | Cerebral hypomyelination (HP:0006808) | 2.52940298 |
| 28 | Focal motor seizures (HP:0011153) | 2.46708631 |
| 29 | Respiratory difficulties (HP:0002880) | 2.46405447 |
| 30 | Inability to walk (HP:0002540) | 2.45418898 |
| 31 | Orchitis (HP:0100796) | 2.43929120 |
| 32 | Hemiparesis (HP:0001269) | 2.39496731 |
| 33 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.35201039 |
| 34 | Albinism (HP:0001022) | 2.33031431 |
| 35 | Large eyes (HP:0001090) | 2.32227736 |
| 36 | Microretrognathia (HP:0000308) | 2.32225874 |
| 37 | Severe visual impairment (HP:0001141) | 2.31920489 |
| 38 | Pigmentary retinal degeneration (HP:0001146) | 2.22919481 |
| 39 | Hepatocellular necrosis (HP:0001404) | 2.21544166 |
| 40 | Recurrent skin infections (HP:0001581) | 2.19777255 |
| 41 | Autoimmune hemolytic anemia (HP:0001890) | 2.19061438 |
| 42 | Increased CSF lactate (HP:0002490) | 2.18470161 |
| 43 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.15487718 |
| 44 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.15487718 |
| 45 | Abnormality of the ileum (HP:0001549) | 2.12755762 |
| 46 | Hepatic necrosis (HP:0002605) | 2.12064601 |
| 47 | Choroideremia (HP:0001139) | 2.10963065 |
| 48 | Pancreatic cysts (HP:0001737) | 2.10755026 |
| 49 | Abnormality of the aortic arch (HP:0012303) | 2.09985207 |
| 50 | Optic neuritis (HP:0100653) | 2.08992256 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.08992256 |
| 52 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.07988963 |
| 53 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.07882195 |
| 54 | Intention tremor (HP:0002080) | 2.05458829 |
| 55 | Increased intramyocellular lipid droplets (HP:0012240) | 2.04352672 |
| 56 | Retinal atrophy (HP:0001105) | 2.03713956 |
| 57 | Mitochondrial inheritance (HP:0001427) | 2.02244663 |
| 58 | Difficulty running (HP:0009046) | 1.99579213 |
| 59 | Tented upper lip vermilion (HP:0010804) | 1.99286966 |
| 60 | Methylmalonic acidemia (HP:0002912) | 1.98891978 |
| 61 | Progressive macrocephaly (HP:0004481) | 1.98176184 |
| 62 | Medial flaring of the eyebrow (HP:0010747) | 1.94214056 |
| 63 | Abnormality of urine glucose concentration (HP:0011016) | 1.91238710 |
| 64 | Glycosuria (HP:0003076) | 1.91238710 |
| 65 | Absent speech (HP:0001344) | 1.91188962 |
| 66 | Acute necrotizing encephalopathy (HP:0006965) | 1.90341643 |
| 67 | Hamartoma of the eye (HP:0010568) | 1.88668462 |
| 68 | Abnormality of chromosome stability (HP:0003220) | 1.88599307 |
| 69 | Pancreatic fibrosis (HP:0100732) | 1.87989651 |
| 70 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86201663 |
| 71 | Facial shape deformation (HP:0011334) | 1.83150456 |
| 72 | Potter facies (HP:0002009) | 1.83150456 |
| 73 | Chorioretinal atrophy (HP:0000533) | 1.81402727 |
| 74 | Delayed gross motor development (HP:0002194) | 1.79511888 |
| 75 | Ragged-red muscle fibers (HP:0003200) | 1.79466198 |
| 76 | Renal cortical cysts (HP:0000803) | 1.79361337 |
| 77 | Methylmalonic aciduria (HP:0012120) | 1.78651885 |
| 78 | Abnormality of vitamin B metabolism (HP:0004340) | 1.78379075 |
| 79 | Aqueductal stenosis (HP:0002410) | 1.77840014 |
| 80 | Hypertensive crisis (HP:0100735) | 1.72985894 |
| 81 | Hydroxyprolinuria (HP:0003080) | 1.72685540 |
| 82 | Abnormality of proline metabolism (HP:0010907) | 1.72685540 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 1.72502984 |
| 84 | Prolonged bleeding time (HP:0003010) | 1.71668190 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 1.71543610 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71543610 |
| 87 | Spastic paraparesis (HP:0002313) | 1.70667800 |
| 88 | Hyperpituitarism (HP:0010514) | 1.69995374 |
| 89 | Episodic fever (HP:0001954) | 1.69609692 |
| 90 | Abnormality of macular pigmentation (HP:0008002) | 1.69505329 |
| 91 | Increased serum lactate (HP:0002151) | 1.69390280 |
| 92 | Renal Fanconi syndrome (HP:0001994) | 1.67261524 |
| 93 | Gaze-evoked nystagmus (HP:0000640) | 1.67035741 |
| 94 | Parakeratosis (HP:0001036) | 1.66849244 |
| 95 | Tubular atrophy (HP:0000092) | 1.66702759 |
| 96 | Amelogenesis imperfecta (HP:0000705) | 1.66645814 |
| 97 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.66630081 |
| 98 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.64084961 |
| 99 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.64084961 |
| 100 | Gastrointestinal atresia (HP:0002589) | 1.63458345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.51799628 |
| 2 | ADRBK2 | 5.52953264 |
| 3 | PINK1 | 4.06062245 |
| 4 | STK24 | 3.63931880 |
| 5 | STK38L | 3.22833837 |
| 6 | ACVR1B | 2.52200002 |
| 7 | MST4 | 2.35579777 |
| 8 | STK39 | 2.14932605 |
| 9 | PAK3 | 2.14212603 |
| 10 | GRK1 | 1.96956694 |
| 11 | OXSR1 | 1.93316737 |
| 12 | EIF2AK3 | 1.90607008 |
| 13 | BMPR1B | 1.86972278 |
| 14 | PBK | 1.85777609 |
| 15 | LIMK1 | 1.78001540 |
| 16 | IRAK3 | 1.71719110 |
| 17 | ADRBK1 | 1.71288948 |
| 18 | FGFR2 | 1.66338147 |
| 19 | ERN1 | 1.57310066 |
| 20 | PRKCE | 1.45525498 |
| 21 | DYRK3 | 1.43018102 |
| 22 | MKNK2 | 1.38567868 |
| 23 | TGFBR1 | 1.30634053 |
| 24 | NEK9 | 1.30536448 |
| 25 | STK3 | 1.12012671 |
| 26 | STK38 | 1.06557981 |
| 27 | DDR2 | 1.06416494 |
| 28 | STK16 | 0.99479872 |
| 29 | BRD4 | 0.97828218 |
| 30 | MKNK1 | 0.91598322 |
| 31 | PRKCG | 0.89967867 |
| 32 | ZAP70 | 0.80747429 |
| 33 | TRPM7 | 0.78965179 |
| 34 | GRK6 | 0.78481095 |
| 35 | TNIK | 0.76695771 |
| 36 | PRKCI | 0.74710125 |
| 37 | TEC | 0.73819253 |
| 38 | CDK9 | 0.72971425 |
| 39 | MAP3K3 | 0.72722769 |
| 40 | CAMK2D | 0.72575638 |
| 41 | PLK2 | 0.69657753 |
| 42 | MAP2K3 | 0.69562736 |
| 43 | CAMK2A | 0.69498911 |
| 44 | TXK | 0.68772849 |
| 45 | BCKDK | 0.68509994 |
| 46 | HCK | 0.66792442 |
| 47 | SYK | 0.66727825 |
| 48 | EIF2AK2 | 0.66029960 |
| 49 | DAPK2 | 0.64398668 |
| 50 | FER | 0.63648973 |
| 51 | TNK2 | 0.61791922 |
| 52 | TESK1 | 0.54345483 |
| 53 | PRKD2 | 0.54135120 |
| 54 | CHEK2 | 0.53974366 |
| 55 | STK10 | 0.52084307 |
| 56 | OBSCN | 0.51717999 |
| 57 | ABL1 | 0.50730617 |
| 58 | MAPK11 | 0.50561501 |
| 59 | PNCK | 0.48474809 |
| 60 | PDK2 | 0.46673211 |
| 61 | TBK1 | 0.46448751 |
| 62 | IKBKB | 0.45678328 |
| 63 | CSNK1A1L | 0.45485438 |
| 64 | GSK3A | 0.45409888 |
| 65 | CLK1 | 0.44495717 |
| 66 | CDC7 | 0.43318558 |
| 67 | MAPK13 | 0.42130674 |
| 68 | GRK7 | 0.41971129 |
| 69 | CSNK2A2 | 0.41607712 |
| 70 | PAK2 | 0.41228922 |
| 71 | NME2 | 0.39870619 |
| 72 | MAP2K6 | 0.39735920 |
| 73 | ERBB3 | 0.39090590 |
| 74 | MAP2K1 | 0.38351578 |
| 75 | WNK4 | 0.38017921 |
| 76 | TYK2 | 0.37371260 |
| 77 | MAPKAPK3 | 0.37267985 |
| 78 | PLK3 | 0.36563912 |
| 79 | SRPK1 | 0.36269187 |
| 80 | PHKG2 | 0.36185853 |
| 81 | PHKG1 | 0.36185853 |
| 82 | RPS6KB2 | 0.36153946 |
| 83 | CSNK1G2 | 0.35061244 |
| 84 | LCK | 0.34541112 |
| 85 | PRKD1 | 0.34499474 |
| 86 | AKT2 | 0.33932167 |
| 87 | CSNK1A1 | 0.33353910 |
| 88 | PRKCQ | 0.32863186 |
| 89 | PRKACB | 0.32090783 |
| 90 | AURKB | 0.31954891 |
| 91 | CSNK1G3 | 0.31907342 |
| 92 | PRKCA | 0.31546201 |
| 93 | CDC42BPA | 0.30176254 |
| 94 | ATM | 0.28819345 |
| 95 | ATR | 0.28816080 |
| 96 | INSR | 0.24470129 |
| 97 | BMPR2 | 0.23986312 |
| 98 | CSNK1G1 | 0.23480284 |
| 99 | BTK | 0.22886699 |
| 100 | MAPK3 | 0.22769173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 3.94060136 |
| 2 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.62345692 |
| 3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.37588253 |
| 4 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 3.00142374 |
| 5 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.76802017 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.74605543 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.61612557 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.45010986 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.35547153 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.30021530 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.24712494 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.19694050 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 2.11615892 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.00708058 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.96652455 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.89824685 |
| 17 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.75723686 |
| 18 | Phototransduction_Homo sapiens_hsa04744 | 1.72842104 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.72478992 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.71671779 |
| 21 | Mineral absorption_Homo sapiens_hsa04978 | 1.70439765 |
| 22 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.69065829 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.68402999 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.57855258 |
| 25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.47200513 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.45468134 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.41907640 |
| 28 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.41511114 |
| 29 | Purine metabolism_Homo sapiens_hsa00230 | 1.36597487 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.31953661 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30728980 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24374425 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20882299 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.17034644 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10985952 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99412171 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98946825 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.98284210 |
| 39 | Salivary secretion_Homo sapiens_hsa04970 | 0.97639448 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96634208 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 0.95885955 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 0.95047521 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93470542 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92099732 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86747920 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.86654470 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86128619 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85510628 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85101855 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.84938406 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.83704582 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82610360 |
| 53 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.79691352 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.79582910 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79157945 |
| 56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.77076106 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72011867 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.69024968 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68851028 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67160320 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66908591 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65763363 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62943619 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60968951 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.59468777 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56851150 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55156007 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54339161 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53274651 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52146189 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.49929920 |
| 72 | Protein export_Homo sapiens_hsa03060 | 0.48796068 |
| 73 | Base excision repair_Homo sapiens_hsa03410 | 0.47597114 |
| 74 | Taste transduction_Homo sapiens_hsa04742 | 0.45925795 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45097020 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43526200 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42822190 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.42261387 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.41490732 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40690675 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.38426872 |
| 82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38155853 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37218739 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35213442 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34349096 |
| 86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.33102165 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32934818 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32881399 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31420063 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.29658924 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29037030 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.28597459 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28535177 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28188822 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28092810 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.27715531 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.27624835 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27611213 |
| 99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25808370 |
| 100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25215085 |

